Drug profile

The FDA adverse-event record for Doxycycline Hyclate

121 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Doxycycline Hyclate. See the species affected, top reactions, and outcomes below.

121
adverse-event reports
1.7%
death-coded share
Unknown
most-reported species
11
Containers, Abnormal - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
121
Total Reports
2
Deaths Reported
1.7%
Death Rate

Active Ingredients

Doxycycline Hyclate

Administration Routes

UnknownOralOtherTopicalSublingualIntralesionalDentalPeriodontal

Species Affected

Unknown 63
Dog 50
Cat 5
Human 3

Most Affected Breeds

Unknown 66
Chihuahua 9
Domestic Shorthair 5
Retriever - Labrador 4
Dachshund (unspecified) 3
Terrier - Jack Russell 3
Beagle 2
Shepherd Dog - German 2
Retriever - Golden 2
Spaniel (unspecified) 2

Most Reported Reactions

Containers, Abnormal 11
Uncoded sign 10
Underfilling, Container 10
Underfilling, Package 9
Lethargy (see also Central nervous system depression in 'Neurological') 8
Gingival disorder 7
Gel/Paste, Abnormal 6
Device Defective NOS 6
Vomiting 5
Application site swelling 4
Facial swelling (see also 'Skin') 4
Anorexia 4

Outcome Breakdown

Ongoing
40 (67.8%)
Recovered/Normal
10 (16.9%)
Outcome Unknown
7 (11.9%)
Euthanized
1 (1.7%)
Died
1 (1.7%)

Doxycycline Hyclate Adverse Event Insights

121 reports name Doxycycline Hyclate; 2 recorded a death outcome (1.7% of reported events, not a population-level mortality rate). Active ingredient: Doxycycline Hyclate. Administration routes: Unknown, Oral, Other, Topical.

By species: Unknown (63 reports), Dog (50 reports), Cat (5 reports). By breed: Unknown (66), Chihuahua (9), Domestic Shorthair (5).

Leading clinical signs: Containers, Abnormal (11), Uncoded sign (10), Underfilling, Container (10), Underfilling, Package (9). Outcome, 59 coded reports: Ongoing leads at 67.8%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.